| 2 | CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation显示文摘Autosomal dominant polycystic kidney disease(ADPKD)is characterized by progressive enlargement of fluid-filled cysts,causing nephron loss and a decline in renal function.Mammalian target of rapamycin(mTOR)is overactive in cyst-lining cells and contributes to abnormal cell proliferation and cyst enlargement;however,the mechanism for mTOR stimulation remains unclear.We discovered that calcium/calmodulin(CaM)dependent kinase IV(CaMK4),a multifunctional kinase,is overexpressed in the kidneys of ADPKD patients and PKD mouse models.In human ADPKD cells,CaMK4 knockdown reduced mTOR abundance and the phosphorylation of ribosomal protein S6 kinase(S6K),a downstream target of mTOR.Pharmacologic inhibition of CaMK4 with KN-93 reduced phosphorylated S6K and S6 levels and inhibited cell proliferation and in vitro cyst formation of ADPKD cells.Moreover,inhibition of calcium/CaM-dependent protein kinase kinase-βand CaM,two key upstream regulators of CaMK4,also decreased mTOR signaling.The effects of KN-93 were independent of the liver kinase B1-adenosine monophosphate-activated protein kinase(AMPK)pathway,and the combination of KN-93 and metformin,an AMPK activator,had additive inhibitory effects on mTOR signaling and in vitro cyst growth.Our data suggest that increased CaMK4 expression and activity contribute to mTOR signaling and the proliferation of cystic cells of ADPKD kidneys. | Yan Zhang Emily A.Daniel July Metcalf Yuqiao Dai Gail A.Reif Darren P.Wallace | 2022 | Journal of Molecular Cell Biology2022，14，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员